AVTR Share Price | Avantor, Inc. Stock Analysis & Recommendation

Q: How big is Avantor, Inc.?

As of Jun 18, Avantor, Inc. has a market capitalization of 8,960.80 million, categorizing it as a Mid Cap company.As of Jun 18, the sum of net sales for the latest four quarters is 6,685.20 million, while the sum of consolidated net profit for the same period is 715.60 million.As of Dec 24, the reporting period shows shareholder's funds amounting to 5,956.70 million and total assets of 12,114.50 million.

Q: What does Avantor, Inc. do?

Overview: Avantor, Inc. is a global provider of mission-critical products and services in the specialty chemicals industry, categorized as a mid-cap company.Financial Snapshot: Net Sales: 1,581 Million (Quarterly Results - Mar 2025) Net Profit: 64 Million (Quarterly Results - Mar 2025) Market Cap: USD 8,960.80 Million (Mid Cap)Key Metrics: P/E: 11.00 Dividend Yield: 0.00% Debt-Equity: 0.62 Return on Equity: 12.74% Price to Book: 1.47Contact Details: Address: Building One, 100 W Matsonford Rd Ste 200 RADNOR PA : 19087 Tel: 1 610 3861700 Website: https://www.avantorsciences.com/

Q: Who are in the management team of Avantor, Inc.?

As of March 2022, the management team of Avantor, Inc. includes the following individuals:- Mr. Rajiv Gupta, who serves as the Chairman of the Board.- Mr. Michael Stubblefield, who is the President, Chief Executive Officer, and a Director.- Mr. Matthew Holt, who is a Director.- Mr. Andre Moura, who is a Director.- Ms. Jo Natauri, who is a Director.- Mr. Juan Andres, who is an Independent Director.- Mr. Jonathan Peacock, who is also an Independent Director. This team plays a crucial role in guiding the company's strategic direction and operations.

Q: Is Avantor, Inc. overvalued or undervalued?

As of 17 October 2025, the valuation grade for Avantor, Inc. has moved from expensive to attractive, indicating a shift towards a more favorable assessment. The company appears undervalued, particularly when considering its P/E ratio of 11, which is significantly lower than the industry average, and a PEG ratio of 0.16, suggesting strong growth potential relative to its price. Additionally, the EV to EBITDA ratio stands at 11.44, which further supports the attractive valuation.In comparison to its peers, Avantor's P/E ratio of 11.82 is notably lower than Westlake Corp.'s 82.20 and Albemarle Corp.'s -101.94, while NewMarket Corp. has a P/E of 16.30, indicating that Avantor is trading at a discount relative to some competitors. Despite recent underperformance, with a year-to-date return of -29.85% compared to the S&P 500's 13.30%, the current valuation metrics suggest that Avantor may present a compelling investment opportunity moving forward.

Q: Is Avantor, Inc. technically bullish or bearish?

As of 24 October 2025, the technical trend for Avantor, Inc. has changed from mildly bearish to sideways. The current technical stance is neutral, with mixed signals across different indicators. The weekly MACD is mildly bullish, while the monthly MACD is bearish. The RSI shows no signal on the weekly timeframe but is bullish on the monthly. Bollinger Bands indicate a bullish stance weekly but mildly bearish monthly. Moving averages are mildly bearish on the daily timeframe. Dow Theory and OBV both suggest a mildly bullish outlook on the weekly and monthly charts.In terms of performance, Avantor has outperformed the S&P 500 over the past week and month, with returns of 4.19% and 28.23% respectively, but has significantly underperformed over longer periods, including a year-to-date return of -26.91% compared to the S&P 500's 15.47%.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

6.25 M

Shareholding (Dec 2025)

FII

19.13%

Held by 301 FIIs

DII

13.75%

Held by 147 DIIs

Promoter

2.09%

How big is Avantor, Inc.?

22-Jun-2025

As of Jun 18, Avantor, Inc. has a market capitalization of $8.96 billion, with net sales of $6.69 billion and a net profit of $715.6 million over the last four quarters.

View full answer

What does Avantor, Inc. do?

22-Jun-2025

Avantor, Inc. is a global provider of specialty chemicals and mission-critical products, with net sales of $1.58 billion and a market cap of approximately $8.96 billion as of March 2025. Key financial metrics include a P/E ratio of 11.00 and a return on equity of 12.74%.

View full answer

Who are in the management team of Avantor, Inc.?

22-Jun-2025

As of March 2022, Avantor, Inc.'s management team includes Chairman Rajiv Gupta, CEO Michael Stubblefield, and Directors Matthew Holt, Andre Moura, Jo Natauri, Juan Andres, and Jonathan Peacock. They are responsible for the company's strategic direction and operations.

View full answer

Is Avantor, Inc. overvalued or undervalued?

21-Oct-2025

As of October 17, 2025, Avantor, Inc. is considered an attractive investment due to its low P/E ratio of 11, strong growth potential indicated by a PEG ratio of 0.16, and favorable EV to EBITDA ratio of 11.44, despite a year-to-date return of -29.85%.

View full answer

Is Avantor, Inc. technically bullish or bearish?

28-Oct-2025

As of October 24, 2025, Avantor, Inc. shows a neutral technical trend with mixed signals, mildly bullish weekly MACD, bearish monthly MACD, and has outperformed the S&P 500 recently but underperformed year-to-date.

View full answer

Compare Avantor, Inc. with Similar Stocks

Westlake Corp.Albemarle Corp.LyondellBasell Industries NV

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Poor Management Efficiency with a low ROCE of 9.33%

The company has been able to generate a Return on Capital Employed (avg) of 9.33% signifying low profitability per unit of total capital (equity and debt)

Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 9.33%

Risky -

Consistent Underperformance against the benchmark over the last 3 years

Mojo Parameters

Stock DNA

Industry

Specialty Chemicals

Market cap

USD 5,190 Million (Small Cap)

P/E

18.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.65

Return on Equity

5.20%

Price to Book

0.93

Revenue and Profits:

Net Sales:

1,664 Million

(Quarterly Results - Dec 2025)

Net Profit:

52 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-32.16%

6 Months

-41.6%

1 Year

-55.85%

2 Years

-70.51%

3 Years

-63.81%

4 Years

-78.63%

5 Years

-73.32%

Avantor, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

0.49%

EBIT Growth (5y)

-4.31%

EBIT to Interest (avg)

3.33

Debt to EBITDA (avg)

3.89

Net Debt to Equity (avg)

0.62

Sales to Capital Employed (avg)

0.66

Tax Ratio

16.69%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

9.33%

ROE (avg)

14.11%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.93

EV to EBIT

15.24

EV to EBITDA

8.90

EV to Capital Employed

0.96

EV to Sales

1.34

PEG Ratio

Dividend Yield

ROCE (Latest)

6.29%

ROE (Latest)

5.20%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

Bullish

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 120 Schemes (65.01%)

Foreign Institutions

Held by 301 Foreign Institutions (19.13%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 2.45% vs -3.54% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 107.36% vs -1,200.15% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,663.60",
          "val2": "1,623.80",
          "chgp": "2.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "239.30",
          "val2": "242.90",
          "chgp": "-1.48%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "53.50",
          "val2": "58.10",
          "chgp": "-7.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-6.90",
          "val2": "-785.50",
          "chgp": "99.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "52.40",
          "val2": "-711.80",
          "chgp": "107.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "81.80%",
          "val2": "85.20%",
          "chgp": "-0.34%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -3.41% vs -2.64% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -174.52% vs 121.58% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "6,552.20",
          "val2": "6,783.60",
          "chgp": "-3.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "997.90",
          "val2": "1,135.70",
          "chgp": "-12.13%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "221.60",
          "val2": "328.30",
          "chgp": "-32.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-824.20",
          "val2": "-90.20",
          "chgp": "-813.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-530.20",
          "val2": "711.50",
          "chgp": "-174.52%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "89.70%",
          "val2": "107.60%",
          "chgp": "-1.79%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

1,663.60

1,623.80

2.45%

Operating Profit (PBDIT) excl Other Income

239.30

242.90

-1.48%

Interest

53.50

58.10

-7.92%

Exceptional Items

-6.90

-785.50

99.12%

Consolidate Net Profit

52.40

-711.80

107.36%

Operating Profit Margin (Excl OI)

81.80%

85.20%

-0.34%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is 2.45% vs -3.54% in Sep 2025

Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is 107.36% vs -1,200.15% in Sep 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

6,552.20

6,783.60

-3.41%

Operating Profit (PBDIT) excl Other Income

997.90

1,135.70

-12.13%

Interest

221.60

328.30

-32.50%

Exceptional Items

-824.20

-90.20

-813.75%

Consolidate Net Profit

-530.20

711.50

-174.52%

Operating Profit Margin (Excl OI)

89.70%

107.60%

-1.79%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -3.41% vs -2.64% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -174.52% vs 121.58% in Dec 2024

All Annual Results

Company CV

About Avantor, Inc.

Avantor, Inc.

Specialty Chemicals

Avantor, Inc. is a global provider of mission critical products and services. Its products include materials and consumables, equipment and instrumentation, and services and specialty procurement. Materials and consumables includes chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits and education and microbiology and clinical trial kits. Equipment and instrumentation includes filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets and critical environment supplies. Services and specialty procurement include onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services.

Company Coordinates

Company Details

Building One, 100 W Matsonford Rd Ste 200 RADNOR PA : 19087

Tel: 1 610 3861700

https://www.avantorsciences.com/

Registrar Details